about
Vitamin E for Alzheimer's dementia and mild cognitive impairmentVitamin E for Alzheimer's disease and mild cognitive impairmentBiological markers of amyloid beta-related mechanisms in Alzheimer's diseaseProtein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseasesPlatelet biomarkers in Alzheimer's diseaseNew pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugsCerebrospinal fluid and blood biomarkers in Alzheimer's diseaseFluid Biomarkers of Traumatic Brain Injury and Intended Context of UseAmyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's DiseaseUpdate on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.The Alzheimer's disease neuroimaging initiative.Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's diseaseBrain type carnosinase in dementia: a pilot study.Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.Prediction of S-glutathionylated proteins progression in Alzheimer's transgenic mouse model using principle component analysisAn overview of biomarkers in Alzheimer's disease.Factor structure of the National Alzheimer's Coordinating Centers uniform dataset neuropsychological battery: an evaluation of invariance between and within groups over time.An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin.Interactions between the apolipoprotein E ε4 allele status and adverse childhood experiences on depressive symptoms in older adultsAssociation of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.Identification and quantification of amyloid beta-related peptides in human plasma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Biological markers for early detection and pharmacological treatment of Alzheimer's disease.Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).BACE1 as a potential biomarker for Alzheimer's diseaseBlood serum miRNA: non-invasive biomarkers for Alzheimer's disease.Biofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer's disease in vitro.Raman spectroscopy of blood serum for Alzheimer's disease diagnostics: specificity relative to other types of dementiaEstimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients.Fluid biomarkers in Alzheimer disease.Enhanced Detection of Low-Abundance Human Plasma Proteins by Integrating Polyethylene Glycol Fractionation and Immunoaffinity DepletionCholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease.Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there?Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study.Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease.Plasma Amyloid-β Peptides and Homocysteine in Depression in the Homebound Elderly.Fluid biomarkers in Alzheimer's disease - current concepts
P2860
Q24202844-A6A357E9-FCAE-4005-85CC-4289EF70EA41Q24241955-BD599FAC-FDCE-4FDC-A11F-D9D3EDDCBC96Q24622136-CC3058FC-1F92-42C1-8C69-D5F6BD7F7D7FQ24650014-4FB48723-EA39-40D9-B2DC-B4ECDB827CFAQ26858851-53237424-32BF-467A-A476-D901ED112455Q26866006-EDE179DC-A5E0-4E69-AB31-AB832B0B7128Q27023758-A83F3EEB-BE20-491A-A394-64D44FEF5ABDQ28066813-62AFFF24-5ED8-4EF2-AAE5-757DD6DE7269Q30385357-FC8EB036-56FE-4942-97F0-200E50CD4A85Q30845482-52EEF219-9043-4A99-B189-8956988A6463Q31030939-921A6A66-344C-43E9-92CA-3888AC5E2512Q33287487-11C25CAD-7A0C-4F6A-85E6-17A426FE4FB7Q33305023-84AD9D6E-4703-403D-870F-A3F6CAC6C71BQ33737093-A58DCC91-E4A1-4F30-AE51-C59CF368F015Q34056793-FA93E050-E96A-41A1-B999-65AEC308528EQ34155662-59512614-EA27-4C57-8F40-23A77B351A5EQ34292024-C7D3AD90-68F9-4748-B165-976F32499EB4Q34466540-96948E4C-AF05-4FD9-8DAC-E3E3920DE4BDQ34574944-9F8D6208-94CA-46CA-A5BA-9DFAACCCF6B0Q35004793-BF58426B-1D72-4E9E-A958-11E4C0CF2982Q35016567-DEBE6EF3-B970-4B8A-89D8-F3EA8786E981Q35024426-572F7183-6D28-4666-BC3C-FE2728A4477EQ35034130-9E7DDCA3-7A2B-4CAD-A50B-ABACC97FF478Q35118876-11CC019D-A6D8-4F04-9F41-61DAD591EDE0Q35237100-D73471AA-69F0-4309-B037-F7590B9DB167Q35675907-926A2ACD-3A54-43B8-A2D8-CAE1D8FB7656Q35781558-B4099BB6-4AF2-49A1-B160-27FDF99C426AQ35856328-BC063CC1-3CA2-4154-9529-EFC51D7D202BQ35991723-31F2E4CF-C795-4987-8664-121A85864849Q36015518-990D1401-8B88-438B-A9F7-8EED90E87845Q36074237-A3A14F13-748F-40EF-AD90-1A2C2F648082Q36086092-D162ABC0-85D3-416C-9680-83A659F8927CQ36186513-347B2772-7177-4EFD-BDD4-A06B09560B1EQ36188829-6189C71E-4215-44A2-B2CA-265676F9D412Q36492343-A84B4FE3-A7F3-4E5D-BB19-AE393252EFE6Q36607324-29812BC8-3987-4E6C-B175-444E1AA6C159Q36632984-FBFA1107-85FB-4EA3-95BC-30F2D09091B8Q36919081-9978EEA1-A36C-4A00-B4F3-7C3585840BEAQ36919567-9B778855-E134-4C59-80FC-BAC13516869DQ36953503-01687509-48B5-4552-A468-5619D8FD872D
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Biomarkers of Alzheimer disease in plasma
@ast
Biomarkers of Alzheimer disease in plasma
@en
type
label
Biomarkers of Alzheimer disease in plasma
@ast
Biomarkers of Alzheimer disease in plasma
@en
prefLabel
Biomarkers of Alzheimer disease in plasma
@ast
Biomarkers of Alzheimer disease in plasma
@en
P2860
P356
P1433
P1476
Biomarkers of Alzheimer disease in plasma
@en
P2093
Michael C Irizarry
P2860
P304
P356
10.1602/NEURORX.1.2.226
P577
2004-04-01T00:00:00Z